Hybrid approaches to clinical trial monitoring: Practical alternatives to 100% source data verification
For years, a vast majority of clinical trial industry has followed the 6-0 igora vibrance tenet of 100% source data verification (SDV).This has been driven partly by the overcautious approach to linking quality of data to the extent of monitoring and SDV and partly by being on the safer side of regulations.The regulations however, do not state any